Women without HOXA13 gene mutation need not be subjected to X-rays

Hugh S. Taylor, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, and colleagues have found that women without mutations of the HOXA13 gene do not need to be subjected to x-rays and other tests for a rare condition called hand-foot genital syndrome. The research is presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.

Hand-foot genital syndrome affects the development of the hands and feet, the urinary tract, and the reproductive system. Some women with this disorder could be at increased risk of pregnancy loss, premature labor and stillbirth. Hand-foot genital syndrome is caused by mutations in the HOXA13 gene, which is one of the genes that control the development of the uterus.

Taylor and colleagues studied women who had classic hand-foot genital syndrome and found a new mutation in the gene that had not been described before. The team then looked at women with other uterine disorders and did not find any mutations in HOXA 13. This ruled out the possibility that they could have hand-foot genital syndrome.

"This finding reduces the need for women to undergo these unnecessary and expensive tests," said Taylor.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Engineered virus-like particles evolve for superior gene delivery efficiency